British drugmaker AstraZeneca mentioned on Saturday it believed its COVID-19 vaccine, developed with the College of Oxford, may defend towards extreme illness attributable to the South African variant of the virus.
AstraZeneca confirmed that early knowledge from a small trial, first reported by the Monetary Occasions, had proven restricted efficacy for the vaccine towards gentle illness primarily attributable to this variant.
“We do imagine our vaccine may defend towards extreme illness, as neutralising antibody exercise is equal to that of different COVID-19 vaccines which have demonstrated exercise towards extra extreme illness, significantly when the dosing interval is optimised to 8-12 weeks,” a spokesman mentioned in an announcement.
A letter from the Editor
Pricey reader,
Now we have been protecting you recent with data on the developments in India and the world which have a bearing on our well being and wellbeing, our lives and livelihoods, throughout these tough instances. To allow huge dissemination of stories that’s in public curiosity, now we have elevated the variety of articles that may be learn free, and prolonged free trial intervals. Nevertheless, now we have a request for individuals who can afford to subscribe: please do. As we battle disinformation and misinformation, and maintain apace with the happenings, we have to commit larger sources to information gathering operations. We promise to ship high quality journalism that stays away from vested curiosity and political propaganda.
Support Quality Journalism
A letter from the Editor
Pricey subscriber,
Thanks!
Your help for our journalism is invaluable. It’s a help for reality and equity in journalism. It has helped us maintain apace with occasions and happenings.
The Hindu has at all times stood for journalism that’s within the public curiosity. At this tough time, it turns into much more essential that now we have entry to data that has a bearing on our well being and well-being, our lives, and livelihoods. As a subscriber, you aren’t solely a beneficiary of our work but additionally its enabler.
We additionally reiterate right here the promise that our group of reporters, copy editors, fact-checkers, designers, and photographers will ship high quality journalism that stays away from vested curiosity and political propaganda.
Suresh Nambath